# STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS

> **NCT04756531** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 70 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PF-07321332 Dose 1
- **DRUG:** PF-07321332 Dose 2
- **DRUG:** PF-07321332 Dose 3
- **DRUG:** PF-07321332 Dose 4
- **DRUG:** PF-07321332 Dose 5
- **DRUG:** PF-07321332 Dose 4 or Placebo (Fed)

## Key facts

- **NCT ID:** NCT04756531
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-11
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04756531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04756531, "STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04756531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*